The board of directors of Genocea Biosciences, Inc. designated Michael Alfieri as Principal Financial Officer and Principle Accounting Officer of the Company. Mr. Alfieri, has been Vice President of Finance of the Company since May 2018 and will retain this position. Before joining the Company, Mr. Alfieri served as Vice President of Finance of Radius Health, Inc. from January 2017 through May 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 58 | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.96% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- GNCAQ Stock
- News Genocea Biosciences, Inc.
- Genocea Biosciences, Inc. Appoints Michael Alfieri as Principal Financial Officer and Principle Accounting Officer